Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Machine learning-powered integration of global proteomics and ex vivo sensitivity unveils a protein signature predictive of treatment success to AML therapy: Validation in patients treated with FHD-286, a SMARCA2/4 dual inhibitor

James Sorrentino, Salvador Martinez-Bartolome, Mahan Abbasian, Antonius Koller, Denice Hickman, Alexis Khalil, Nikhil Pandit, Kim Horrigan, Mary-Elizabeth Percival, Derek Stirewalt, Alfonso Quintas-Cardama, Pilgrim Jackson

Blood (2025) 146 (Supplement 1): 3498.

https://doi.org/10.1182/blood-2025-3498

Published: 2025

Journal Articles

Genomic and phenotypic impact of FHD-286–induced inhibition of SMARCA4/2 in patients with relapsed/refractory myeloid malignancies

Mike Collins, David Lahr, Eytan Stein, Courtney DiNardo, Ashwin Kishtagari, Brian Ball, Kim Horrigan, Alexis Khalil, Katie D'Aco, Mia Bosinger, Salih Topal, Nicholas Spidale, Alfonso Quintas-Cardama, Gromoslaw Smolen

Blood (2025) 146 (Supplement 1): 655.

https://doi.org/10.1182/blood-2025-655

Published: 2025